

Dopamine(DOPE) Price Live Chart
Dopamine(DOPE) price today is $0.001261, with a 24-hour trading volume of $93.47K and as such Dopamine(DOPE) has a market cap of $34.32K, giving it a market dominance of 0.0000045%. The Dopamine(DOPE) price moved +10.93% in the last 24 hours.
DOPE Price Data
- 24H Volume$93.47K
- All-Time High(ATH)$0.6559
- 24h High$0.001296
- All-Time Low(ATL)$0.0005
- 24h Low$0.001107
DOPE Market Cap Infos
- Market Cap$34.32K
- Fully Diluted Valuation$157.71K
- Market Cap/FDV21.77%
- Market SentimentNeutral
DOPE Supply
- Circulating Supply27.2M DOPE
- Total Supply125M DOPE
- Max Supply125M DOPE
Dopamine(DOPE) is predicted to average $0.001261 in 2025, with a potential swing between the lowest price $0.0006687 and the highest price $0.00164. By 2035, Dopamine(DOPE) price could reach to $0.005903, offering a potential +218.00% return from today’s Dopamine price.
Year | Minimum Price | Highest Price | Average Price | Change |
---|---|---|---|---|
2025 | $0.0006687 | $0.00164 | $0.001261 | -- |
2026 | $0.001131 | $0.001596 | $0.00145 | +15.00% |
2027 | $0.0008226 | $0.001736 | $0.001523 | +20.00% |
2028 | $0.001026 | $0.002298 | $0.00163 | +29.00% |
2029 | $0.001355 | $0.002455 | $0.001964 | +55.00% |
2030 | $0.001392 | $0.00285 | $0.002209 | +75.00% |
2031 | $0.001821 | $0.00339 | $0.00253 | +100.00% |
2032 | $0.001983 | $0.003374 | $0.00296 | +134.00% |
2033 | $0.002755 | $0.003389 | $0.003167 | +151.00% |
2034 | $0.003049 | $0.004753 | $0.003278 | +159.00% |
2035 | $0.003293 | $0.005903 | $0.004016 | +218.00% |
Dopamine(DOPE) price has moved +10.93% in the last 24 hours, and +7.22% in the past 7 days. The price of Dopamine(DOPE) is +6.61% in the past 30 days, and -95.07%over the last year.
Time period | Change amount | % Change |
---|---|---|
1H | +$0.0000002522 | +0.02% |
24H | +$0.0001243 | +10.93% |
7D | +$0.00008496 | +7.22% |
30D | +$0.00007822 | +6.61% |
1Y | -$0.02433 | -95.07% |
About Dopamine (DOPE)
Contract

8kqmghm1m...d3eanwkcd
Explorers
explorer.solana.com
Website
web3intelligence.com
Dopamine (DOPE) Investors


